These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 38645500)

  • 1. Novel drugs affecting diabetic peripheral neuropathy.
    Saleh DO; Sedik AA
    Iran J Basic Med Sci; 2024; 27(6):657-670. PubMed ID: 38645500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic painful neuropathy: current and future treatment options.
    Chong MS; Hester J
    Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Methylfolate in Diabetic Peripheral Neuropathy: A Narrative Review.
    Christofides EA; Valentine V
    Endocr Pract; 2023 Aug; 29(8):663-669. PubMed ID: 37088147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy.
    Yang C; Zhao X; An X; Zhang Y; Sun W; Zhang Y; Duan Y; Kang X; Sun Y; Jiang L; Lian F
    Front Endocrinol (Lausanne); 2023; 14():1136796. PubMed ID: 37056668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine.
    Yang H; Sloan G; Ye Y; Wang S; Duan B; Tesfaye S; Gao L
    Front Endocrinol (Lausanne); 2019; 10():929. PubMed ID: 32010062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for diabetic neuropathy.
    Tahrani AA; Askwith T; Stevens MJ
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):661-83. PubMed ID: 20795891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of translational insights: Neuromodulation in animal models for Diabetic Peripheral Neuropathy.
    Mittal R; McKenna K; Keith G; McKenna E; Sinha R; Lemos JRN; Hirani K
    PLoS One; 2024; 19(8):e0308556. PubMed ID: 39116099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How inflammation dictates diabetic peripheral neuropathy: An enlightening review.
    Cheng Y; Chen Y; Li K; Liu S; Pang C; Gao L; Xie J; Wenjing LV; Yu H; Deng B
    CNS Neurosci Ther; 2024 Apr; 30(4):e14477. PubMed ID: 37795833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Treatment of Painful Diabetic Neuropathy.
    Sloan G; Alam U; Selvarajah D; Tesfaye S
    Curr Diabetes Rev; 2022; 18(5):e070721194556. PubMed ID: 34238163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroacupuncture efficacy in diabetic polyneuropathy: Study protocol for a double-blinded randomized controlled multicenter clinical trial.
    Pérez Hernández MF; Calderón Vallejo A; Aguilar Castillo SJ; Gómez Jiménez DC; Rodríguez Guerrero E; Aguilar Morales F; Moreno Tovar MG; Zurita Muñóz MA; Bautista Cortéz AE; Calzada Mendoza CC; De Nova Ocampo MA; Ordóñez Rodríguez JM; Gómez Esquivel ML; García Méndez A; Flores Gil O; Macías Zaragoza VM; Cortés Moreno GY; Salinas Lara C; Velázquez García G; Saldivar Cerón HI; Pérez Navarro LM; Ávila Jiménez L; Gómez Zamudio JH; Díaz Flores M; Cruz López M; Ocharan Hernández ME; Peralta Romero JJ
    BMC Complement Med Ther; 2024 Feb; 24(1):90. PubMed ID: 38360684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic P2X receptors and diabetic neuropathic pain.
    Shi L; Zhang HH; Hu J; Jiang XH; Xu GY
    Sheng Li Xue Bao; 2012 Oct; 64(5):531-42. PubMed ID: 23090494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment modalities for painful diabetic neuropathy.
    Rastogi A; Jude EB
    Diabetes Metab Syndr; 2021; 15(1):287-293. PubMed ID: 33484985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy.
    Liu C; Wu T; Ren N
    Front Endocrinol (Lausanne); 2023; 14():1268619. PubMed ID: 38313844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diabetic neuropathy: triggers and mechanisms.
    Dobretsov M; Romanovsky D; Stimers JR
    World J Gastroenterol; 2007 Jan; 13(2):175-91. PubMed ID: 17226897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic treatments for diabetic peripheral neuropathy.
    Ziegler D
    Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER stress in diabetic peripheral neuropathy: A new therapeutic target.
    O'Brien PD; Hinder LM; Sakowski SA; Feldman EL
    Antioxid Redox Signal; 2014 Aug; 21(4):621-33. PubMed ID: 24382087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.
    Kessler JA; Shaibani A; Sang CN; Christiansen M; Kudrow D; Vinik A; Shin N;
    Clin Transl Sci; 2021 May; 14(3):1176-1184. PubMed ID: 33465273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy.
    Marshall A; Alam U; Themistocleous A; Calcutt N; Marshall A
    Clin Ther; 2021 Sep; 43(9):1441-1456. PubMed ID: 33906790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic peripheral neuropathy essentials: a narrative review.
    Chang MC; Yang S
    Ann Palliat Med; 2023 Mar; 12(2):390-398. PubMed ID: 36786097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on Mechanistic and Pharmacological Findings of Diabetic Peripheral Neuropathy including Pharmacotherapy.
    Tiwari R; Wal P; Singh P; Tiwari G; Rai A
    Curr Diabetes Rev; 2021; 17(3):247-258. PubMed ID: 32928092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.